Live Breaking News & Updates on Mindy Valcarcel|Page 2
Stay updated with breaking news from Mindy valcarcel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CHICAGO — Zanidatamab exhibited durable antitumor activity among patients with previously treated advanced HER2-amplified biliary tract cancer, according to results of the phase 2B HERIZON-BTC-01 study presented at ASCO Annual Meeting.More than half of patients who received zanidatamb (Jazz Pharmaceuticals/Zymeworks) monotherapy survived at least a year and median OS exceeded 15 months. ....
CHICAGO — Trastuzumab deruxtecan extended PFS compared with standard chemotherapy for certain patients with pretreated breast cancer, according to findings presented at ASCO Annual Meeting.The analysis — which included patients with hormone receptor-positive, HER2-low or HER2-ultralow metastatic breast cancer that progressed after endocrine therapy — also showed considerably ....
CHICAGO — High-deductible health plans appeared associated with shorter survival among cancer survivors, according to results of a nationwide population-based analysis presented at ASCO Annual Meeting.The findings suggest high-deductible health plans may create a financial disincentive for cancer survivors that prevents them from seeking necessary medical care, according to Justin Barnes, ....
William Dale, MD, PhD, FASCO, has experienced a range of emotions since learning he’d receive the B.J. Kennedy Geriatric Oncology Award at this year’s ASCO Annual Meeting.The sense of honor he feels for recognition of his contributions to the field is accompanied by a deep gratitude for two past recipients — the late Arti Hurria, MD, FASCO, who received the award in 2013, ....
CHICAGO — A review of more than 1,700 prior authorization requests related to pain medication for people with cancer showed the vast majority ultimately got approved.However, chart reviews documented uncontrolled pain and unmanageable side effects for many patients whose requests had been denied. ....